Once the hybrid peptide was cleaved in TME, not only could the free anti-PD-L1 peptides bind to PD-L1 on the surface of tumor cells to block tumor cells immune escape, but also allowed the exposed oncolytic peptide MP9 quickly kill tumor cells and release TAAs to induce ICD. This evidence concerns the gene CD274 and neoplasm.